The COVID-19 pandemic drove 45% of clinical trial sites to transition patients from in-person to remote visits using virtual trial solutions.
Disruptions preventing or limiting site access to patients, monitors, and CRAs are propelling long-lasting changes in the research industry, supported by the adoption of virtualization technologies.
- Are you prepared to adopt a virtualization strategy?
- Can you respond to urgent remote requirements for patients and sites?
- Have you and your CRO evolved your technology approach to support fully remote study conduct?
- Will your strategy meet future standards for transforming trials?